Clinical Trial Update: NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe

View source ↗

Summary

The document outlines a clinical trial to evaluate the impact of NPC1L1 gene polymorphisms on the efficacy and safety of Hybutimibe in atherosclerotic cardiovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Hybutimibe (hybutimibe)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Gene Polymorphism, ASCVD | Status: NOT_YET_RECRUITING